You are here

  • Home
  • Archive
  • Volume 92, Issue 1
  • Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology

Article metrics

Article menu
Download PDFPDF
PostScript
Letter
Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology

 

Online download statistics by month:

Online download statistics by month: August 2020 to March 2024

AbstractFullPdf
Aug 202029829071
Sep 202038733265
Oct 202015316128
Nov 20201039843
Dec 202040739959
Jan 202136736072
Feb 202119818740
Mar 202113913244
Apr 202114314361
May 202113613238
Jun 2021838030
Jul 2021909232
Aug 202112110830
Sep 202111511340
Oct 202115214444
Nov 2021696633
Dec 2021817821
Jan 202211811255
Feb 202211310920
Mar 202211210411
Apr 2022859025
May 2022858324
Jun 2022696912
Jul 2022677620
Aug 2022757515
Sep 2022504819
Oct 202267669
Nov 202257558
Dec 202249476
Jan 202349479
Feb 202357576
Mar 2023948017
Apr 20236151
May 20235621
Jun 20235920
Jul 20237102
Aug 202314356
Sep 20239141
Oct 20235310
Nov 20237962
Dec 20239975
Jan 20245243
Feb 20247000
Mar 20246012
Total508340701030